| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/27/2006 | WO2006078834A1 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 07/27/2006 | WO2006078775A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists |
| 07/27/2006 | WO2006078697A1 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/27/2006 | WO2006078283A2 Quinoxaline inhibitors of hedgehog signalling |
| 07/27/2006 | WO2006077851A1 Quinolone derivative and salt thereof |
| 07/27/2006 | WO2006077499A1 Chemical compounds |
| 07/27/2006 | WO2006077366A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | WO2006077364A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | WO2006076845A1 Process for producing rosuvastatin calcium, intermediate for the preparation of the same and process for producing the intermediate |
| 07/27/2006 | US20060167277 New aziridine derivatives and their preparation methods |
| 07/27/2006 | US20060167272 Intermediates for the production of polymethine compounds containing a desired counter ion with high purity and in high yields; improving the solubility in solvents, the compatibility with resins, the durability and the sensitivity to laser beams |
| 07/27/2006 | US20060167269 Compounds and methods for the inhibition of compounds cruzi |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167249 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 07/27/2006 | US20060167080 Use in inhibiting PI-3-kinase activity in mammals; cancer; Acetic acid 4-diallylaminomethylene-6-hydroxy-1- alpha -methoxymeth-yl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta , 12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta[ alpha ]phenanthren-11-yl ester |
| 07/27/2006 | US20060167078 Substituted benzodioxepins |
| 07/27/2006 | US20060167065 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 07/27/2006 | US20060167055 Non-nucleoside reverse transcriptase inhibitors |
| 07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060167015 Inhibitors of tyrosine kinases |
| 07/27/2006 | US20060167008 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060166995 Piperidine-n-oxide-derivatives |
| 07/27/2006 | US20060166991 Pyridine carboxamide derivatives and their use as pesticides |
| 07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
| 07/27/2006 | US20060166988 Novel compounds |
| 07/27/2006 | US20060166985 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/27/2006 | US20060166983 Indole derivatives as ppar modulators |
| 07/27/2006 | US20060166962 2-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methyl}1-oxypiperazinyl)methyl]phenoxy}pyrimidine; insecticide, controlling tobacco budworm, wheat, corn, soybeans, potatoes, and cotton; for soil-borne insects, such as termites and white grubs |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166933 Novel 2H-chromene derivatives as selective estrogen receptor modulators |
| 07/27/2006 | US20060166926 small molecules that modulate premature translation termination and/or nonsense-mediated mRNA decay; treating cystic fibrosis or muscular dystrophy |
| 07/27/2006 | US20060166866 Cell adhesion inhibitors |
| 07/27/2006 | US20060166829 N-Heterocycl phenyl-substituted cyclic ketoenols |
| 07/27/2006 | US20060166197 Building block capable of transferring a functional entity |
| 07/27/2006 | US20060166033 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
| 07/27/2006 | CA2595574A1 Chemical compounds |
| 07/27/2006 | CA2595477A1 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 07/27/2006 | CA2595157A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists |
| 07/27/2006 | CA2594878A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2593155A1 Indoles useful in the treatment of inflammation |
| 07/26/2006 | EP1682539A1 Process for preparing thiazolidinediones |
| 07/26/2006 | EP1682538A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 07/26/2006 | EP1682537A1 Modulators of cellular adhesion |
| 07/26/2006 | EP1682536A1 Process for the manufacture of the calcium salt of rosuvastatin (e)-7-'4-(4-fluorophenyl)-6-isopropyl-2-'methyl(methylsulfonyl)amino ! pyrimidin-5-yl!(3r,5s)-3,5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof |
| 07/26/2006 | EP1682529A2 Methods for synthesizing quinolinone compounds |
| 07/26/2006 | EP1682528A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES |
| 07/26/2006 | EP1682520A1 Amide derivatives |
| 07/26/2006 | EP1682518A1 Dicationic triaryl analogs as anti-protozoan agents |
| 07/26/2006 | EP1682511A2 Methods and compositions for selectin inhibition |
| 07/26/2006 | EP1682509A1 Pyridine carboxylic acid derivatives as glucokinase modulators |
| 07/26/2006 | EP1682499A1 4-biarylyl-1-phenylazetidin-2-ones |
| 07/26/2006 | EP1682140A2 Methods of use of thrombin receptor antagonists |
| 07/26/2006 | EP1682126A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 07/26/2006 | EP1682117A1 2-azetidinones as anti-hypercholesterolemic agents |
| 07/26/2006 | EP1487812A4 Anomeric derivatives of monosaccharides |
| 07/26/2006 | EP1448552B1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 07/26/2006 | EP1036073B1 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
| 07/26/2006 | CN1809561A Phenylacetamides and their use as glucokinase modulators |
| 07/26/2006 | CN1809559A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 07/26/2006 | CN1809558A 4-(aminomethyl)-piperidine benzamides as 5HT4 -antagonists |
| 07/26/2006 | CN1809556A Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 07/26/2006 | CN1809553A Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 07/26/2006 | CN1809552A Cannabinoid derivatives, methods of making, and use thereof |
| 07/26/2006 | CN1809540A Inhibitors of Akt activity |
| 07/26/2006 | CN1809539A Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 |
| 07/26/2006 | CN1809538A Cis-2,4,5-triaryl-imidazolines |
| 07/26/2006 | CN1809362A Substituted 1,4-diazepines and uses thereof |
| 07/26/2006 | CN1809349A 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine A2A receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/26/2006 | CN1266131C Process for the preparation of heterocgclic indene analogs |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081470 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081461 Quinazoline compounds and pharmaceutical compositions containing them |
| 07/25/2006 | US7081454 Anticancer agents |
| 07/25/2006 | US7081279 Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device |
| 07/25/2006 | CA2182105C Chloropyrimide intermediates |
| 07/25/2006 | CA2159603C Quinolines as type iv phosphodiesterase inhibitors |
| 07/20/2006 | WO2006076564A1 Synthesis of himbacine analogs |
| 07/20/2006 | WO2006076529A1 Indole derivatives for treating viral infections |
| 07/20/2006 | WO2006076452A2 An exo-selective synthesis of himbacine analogs |
| 07/20/2006 | WO2006076415A2 Exo- and diastereo- selective syntheses of himbacine analogs |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006074789A1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 07/20/2006 | WO2006047756A3 Substituted tetracycline compounds |
| 07/20/2006 | WO2006015060A3 Isoindoline compounds and methods of their use |
| 07/20/2006 | WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 07/20/2006 | US20060161005 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160881 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| 07/20/2006 | US20060160858 Administering N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide for treating ophthalmic disease which is age related macular degeneration, diabetic retinopathy, or neovascular glaucoma |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160842 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |